ABSTRACT PURPOSE: To report the clinical course of early transient reduction of uncorrected visual acuity (UCVA) after LASIK surgery resulting from steroid-induced elevation of intraocular pressure (IOP).
RESULTS: Intraocular pressure increased by 4 to 30 mmHg from preoperative to postoperative days 4 to 20. Twenty-seven of 29 eyes had a decrease in uncorrected visual acuity and/or BSCVA. All fl aps, except one, had edema without evidence of infl ammation in the interface or the remainder of the cornea. Discontinuation of topical corticosteroids and application of anti-glaucoma medications resulted in a decrease of IOP to normal levels and recovery of BSCVA. L aser in situ keratomileusis (LASIK) is a common surgical procedure performed all over the world. Millions of people have undergone this surgery. Many complications of LASIK have been described in the ophthalmic literature. Elevation of intraocular pressure (IOP) after LASIK has been described as a dramatic event with decrease in uncorrected visual acuity (UCVA), corneal edema and infl ammation, accumulation of fl uid in the interface between the fl ap and the cornea, and erroneously low measurements of IOP with applanation tonometry. [1] [2] [3] [4] However, these dramatic events are rare.
Most refractive surgeons routinely use topical corticosteroids after LASIK surgery. The dose and duration of steroid application differ according to the decision of each surgeon. The use of steroids may cause steroid-induced IOP elevation. The intraocular hypertensive effect of topical steroids is well known in ophthalmology. Becker 5 and Armaly 6 found that 30% to 40% of the normal population may be intermediate responders with a pressure increase of at least 6 mmHg, and a small group of high responders may have elevations of 16 mmHg. Armaly 6 reported a hypertensive effect at the end of the fi rst week in normal patients, with a mean increase in pressure of 19%. High responders had a more rapid and higher increase in pressure (increase of 60%) at the end of the fi rst week of steroid therapy. 6, 7 Mild increase of IOP after LASIK will not affect the vision of most patients and will remain unidentifi ed after the discontinuation of corticosteroids. A signifi cant increase in IOP during the fi rst postoperative days, without interlamellar infl ammation, may cause fl ap edema, changes in corneal con- In this study, we present a group of patients who had an early transient decrease of UCVA and best spectaclecorrected visual acuity (BSCVA) after LASIK, which was associated with steroid-induced elevation of the IOP. Unlike previous reports describing interface fl uid or interface keratitis associated with IOP elevation after LASIK, 4, 8 our patients presented with fl ap edema but without signs of interface fl uid or infl ammatory response. Prior to surgery each eye underwent a complete eye examination. Uncorrected visual acuity (UCVA) and best spectacle-corrected visual acuity (BSCVA), IOP measurement with applanation tonometry, slit-lamp evaluation of the anterior segment, and direct/indirect funduscopy were evaluated. Schirmer test, pupil size evaluation, and topography with EyeSys (EyeSys Technologies, Houston, Tex) and Orbscan (Bausch & Lomb, Rochester, NY) systems were routinely done in all eyes. A standard Snellen chart was used to measure UCVA and BSCVA.
PATIENTS AND METHODS
All eyes underwent LASIK using the Technolas 217 Z laser (Bausch & Lomb). In 8 eyes (4 patients), a wavefront-guided ablation was performed (Zyoptix System, Bausch & Lomb). In the remaining 21 eyes (11 patients), a standard plano-scan ablation was applied. Flaps of 8.5 to 9.5 mm were cut using the Hansatome microkeratome (Bausch & Lomb), and the corrected optical zones ranged from 5.5 to 7.0 mm in diameter. All eyes except one had uneventful procedures. In one eye, an epithelial erosion (2.0ϫ1.5 mm) occurred, which healed within the fi rst two postoperative days with the help of a bandage contact lens.
Routine postoperative treatment included topical application of 0.5% prednisolone acetate 6 times a day for the fi rst 4 postoperative days, tapered to 3 times a day for the following 10 days. Topical 0.3% lomefl oxacine (Novartis Ophthalmics, Hettlingen, Switzerland) was used 4 times a day for the fi rst 4 days. When patients complained of decreased vision postoperatively, and the postoperative UCVA was lower than the preoperative BSCVA by у2 lines, a complete ocular evaluation was performed, including applanation tonometry and refraction. The IOP was measured with Goldmann tonometry in the center of the fl ap.
When the postoperative IOP was Ͼ20 mmHg, topical corticosteroids were discontinued and topical 0.5% timolol maleate twice daily was started. If the IOP was Ͼ30 mmHg, topical 2% pilocarpine 4 times daily was added as well. The topical pilocarpine was discontinued in all patients after 48 hours, when a decrease in IOP was noted. The topical timolol was maintained until the next follow-up, usually within 1 or 2 weeks, when the IOP returned to preoperative levels.
RESULTS
Preoperatively, all patients presented with myopia from Ϫ1.00 to Ϫ13.25 diopters (D) (mean: Ϫ5.4Ϯ2.7 D) and astigmatism from 0 to 5.00 D (Table) . Best spectacle-corrected visual acuity was у20/20 in 21 eyes and 20/25 to 20/40 in 8 eyes. Intraocular pressure was between 11 and 16 mmHg. The remainder of the eye examinations, including evaluation of the anterior and posterior segments, corneal topography, and Schirmer's test, were unremarkable.
One day after LASIK all eyes had UCVA within 2 lines of the preoperative BSCVA, except for one patient who was corrected for monovision. Thirteen of the 15 patients were concerned due to a decrease in UCVA and blurred vision, and called at least once before the scheduled eye examination. These patients attended an unscheduled eye examination within 4 to 20 days postoperatively, and only 2 patients came for a scheduled appointment (Table) .
Postoperatively, most eyes presented with edema of the LASIK fl ap without epithelial edema, whereas the conjunctiva was quiet or mildly hyperemic (Fig 1) . No signs of interface infl ammation were noted, and there was no interface fl uid in any of the patients. In all patients, the corneal stroma was clear with no signs of edema. In all 29 eyes, the applanation tonometry measurements of the IOP were between 16 and 42 mmHg and were higher than the preoperative IOP measurement by 4 to 30 mmHg (P=.001). Best spectacle-corrected visual acuity decreased in 23 eyes by 1 to 3 lines (by 1 line in 11 eyes, by 2 lines in 8 eyes, and by 3 lines in 4 eyes) and remained unchanged in 6 eyes. Twenty-fi ve of 29 eyes had myopia with spherical equivalent refraction ranging from Ϫ0.50 to Ϫ3.50 D. The mean spherical equivalent refraction in all 29 eyes was Ϫ1.18 D.
After the IOP dropped to preoperative (or lower) levels, the IOP-induced myopic shift decreased in 27 eyes by Ϫ0.25 D to Ϫ2.37 D (mean: Ϫ0.89 D). In 2 eyes, the spherical equivalent refraction did not change despite the decrease in the IOP.
In four eyes of two patients that underwent Orbscan topography postoperatively, a remarkable posterior fl oat was documented (Figs 2 and 3 ). In one of these patients, the postoperative posterior fl oat reading was 0.154 mm and this decreased to 0.042 after reduction of the IOP. This reduction of the posterior fl oat value was associated with a decrease of the IOP to the preoperative level, resolution of the fl ap edema, and improvement in UCVA. The Orbscan central corneal thickness reading was 343 µm postoperatively, and this increased to 561 µm after IOP reduction. No signifi cant changes were noted in the anterior elevation and keratometric maps (Figs 2C, 2D, 3C, and 3D).
After discontinuation of topical steroids and use of anti-glaucoma treatment, all patients reported improved UCVA within the fi rst week. The IOP and BSCVA returned to the preoperative values within 1 to 7 days. Flap edema and corneal haze disappeared after the IOP dropped to normal levels and the posterior fl oat, in two patients, decreased as well. In two patients, who were examined 1 and 2 hours after the administration of the anti-glaucoma drugs, the pressures dropped by 7 to 14 mmHg, and a signifi cant decrease of fl ap edema was noted. 
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At fi nal examination at 1 month, IOP was within the preoperative level or lower in all eyes. Uncorrected visual acuity improved by 1 line in 9 eyes, by 2 lines in 6 eyes, by 3 lines in 7 eyes, and by 4, 5, and 6 lines in 2 eyes each, respectively. In 1 eye, there was no change of UCVA. Two eyes lost 1 line of BSCVA, and 4 eyes gained 1 line. In 25 eyes, the fi nal spherical equivalent refraction was within Ϯ0.50 D.
A highly signifi cant correlation was found between the change in IOP and changes in spherical equivalent refraction and BSCVA (Fig 4) . Linear regression analysis between the "net change in IOP" (IOP during the postoperative ocular hypertension Ϫ IOP at the fi nal visit) and the "net change in spherical equivalent refraction" (spherical equivalent refraction during the hypertensive episode Ϫ spherical equivalent refraction after the drop of IOP at the last visit) revealed a highly signifi cant correlation (r 2 =0.493, PϽ.0001). In addition, a signifi cant correlation was demonstrated between the net change in IOP and the "net change in BSCVA" (BSCVA during the hypertensive episode Ϫ BSCVA at the last visit) (r 2 =0.318, P=.0015).
DISCUSSION Elevation of IOP after LASIK has been described previously. 1, 7, 8 Flap edema and accumulation of fl uid in the interface, between the fl ap and the cornea, caused a decrease in vision and erroneously low measurements of IOP by applanation tonometry. [1] [2] [3] [4] However, these events of extreme increase in IOP after LASIK with The etiology of these events usually was attributed to endothelial dysfunction, 9,10 although treatment with topical steroids could have a been a contributing factor. In previous reports of fl ap edema after LASIK, preexisting primary dysfunction of the corneal endothelium was considered the probable etiology.
9,10 However, we believe that in our series, abrupt elevation of the IOP, caused by topical steroid use, caused a transient secondary endothelial failure, leading to fl ap edema.
Fifteen (1%) of the 1492 patients who underwent LASIK reported a signifi cant decrease in UCVA and had IOP elevations in the fi rst 4 to 20 days postoperatively. All eyes except 1 had a decrease in visual acuity (BSCVA or UCVA), but only 3 patients complained of ocular discomfort.
Applanation tonometry revealed elevated IOP in all 29 eyes. In 14 eyes, IOP was у30 mmHg. The rise of IOP was accompanied by a myopic shift, decrease in UCVA, and loss of BSCVA. Interestingly, signifi cant correlations were noted between the myopic spherical equivalent refraction change and IOP shift (PϽ.0001) and between the BSCVA change and IOP shift (P=.0015), which might suggest a direct effect of pressure variations on early residual myopia after LASIK. We did not fi nd signs of intraocular infl ammation, and the optic nerves were normal in all eyes. The decrease in UCVA and loss of BSCVA are most probably related to the fl ap edema, and the myopic shift. Administration of anti-glaucoma treatment caused a rapid drop of IOP and partial recovery of UCVA after 1 or 2 hours. In some patients, a complete recovery of UCVA and BSC-VA and changes in the corneal topography (posterior fl oat) occurred within the fi rst 24 hours after treatment. At the fi nal examination, the pressure in all eyes was normal and no eye lost 2 lines of BSCVA.
Analysis of the Orbscan images performed in two patients may help understand the pathophysiology of the changes in visual acuity and refraction. A marked increase of the posterior fl oat was evident postoperatively (0.154 mm) (see Fig 2A) and this dramatically decreased to 0.042 mm after reduction of the IOP (see Fig 3A) . The increase of the posterior fl oat is probably a result of a transient forward movement of the central cornea as a result of the acute increase of IOP. Although these changes could have been a result of an artifact, caused by different indices of refraction in an edematous cornea, it should be noted that almost no changes were evident on the anterior elevation and keratometric maps. Unfortunately, we were not aware of the IOPrelated posterior fl oat changes and performed these examinations only in the last two patients of this group. The signifi cant topographic changes and myopic shift that fl uctuate in association with IOP variations may indicate the mechanical vulnerability of the cornea to IOP changes in the early postoperative period.
The myopic shift can be explained by one of two possible mechanisms. It may result from the fl ap edema that causes a transient change in the index of refraction, or the sudden IOP elevation may induce a transient increase of the axial length. Taken together, 
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Steroid-induced IOP After LASIK/Frucht-Pery et al our hypothesis for the IOP elevation and myopic shift after LASIK is as follows: topical steroids after LASIK cause IOP elevation, which results in corneal endothelial dysfunction leading to fl ap edema. The increased IOP coupled with a reduced corneal biomechanical strength is responsible for an increase in the axial length. A possible change in the index of refraction of the edematous fl ap may further contribute to this myopic shift. Our patients differ from the reported groups in the literature in that they had elevation of IOP that was not associated with DLK. 1, 3, 4 In the published reports, infl ammation in the interface and intensive use of topical steroids caused steroid-induced glaucoma, severe loss of visual acuity, stromal and fl ap edema, accumulation of fl uid in the interface, erroneously low tonometry measurements, and late diagnosis of glaucoma. 1, 3, 4 In our patients, however, we did not fi nd corneal infl ammation or fl uid accumulation (although microscopic fl uid accumulation would be missed as we did not use confocal microscopy). Our patients had high IOP with applanation tonometry, mild decrease of UCVA, and were diagnosed and treated within days of the procedure. Although the actual applanation pressures might be higher by 2 to 5 mmHg compared to our report, [11] [12] [13] early diagnosis of steroid-induced IOP elevation in our patients led to discontinuation of the steroids, application of anti-glaucoma medications, and recovery of normal visual acuity and IOP within hours. The late diagnosis of steroid-induced IOP elevation after LASIK in some patients with DLK was most probably related to unfamiliarity of surgeons with such a combination of events, particularly when the measured pressures were low. Perhaps the interlamellar infl ammation in the previously reported studies 1, 3, 4 caused endothelial cell dysfunction, increase of corneal edema, and fl uid accumulation in the interface cornea. These events caused prolonged and increased use of topical steroids, a further rise of IOP, and delay in diagnosis of steroid-induced glaucoma.
Decreased visual acuity in the fi rst 2 postoperative weeks requires immediate attention. Although in high myopes an early drop in visual acuity, in an otherwise non-infl amed, asymptomatic eye, may indicate early regression of myopia; in low myopes, early signifi cant regression of myopia with a dramatic decrease in vision is uncommon. In patients with low myopia who use steroids, who are glaucoma suspects, or have a family history of glaucoma, a complaint of decreased visual acuity after LASIK should be treated as an emergency to rule out steroid-induced glaucoma. A typical mild fl ap edema accompanied by residual myopia and loss of UCVA and BSCVA in an otherwise noninfl amed eye may suggest increased IOP. High IOP by applanation tonometry may indicate that the IOP is even higher. [11] [12] [13] Rapid decrease of IOP and a recovery of the UCVA and BSCVA, following administration of anti-glaucoma medication, confi rm the diagnosis of steroid-induced IOP elevation.
Although steroid-induced elevation of the IOP usually starts a few weeks after the initiation of topical steroid therapy, it may manifest within 3 to 5 days in extreme cases of high responders treated with frequent doses of topical steroids, such as hourly application of 1% prednisolone acetate.
14 It is possible that the penetration of the steroid after LASIK surgery is more efficient as a result of the residual erosions in the conjunctiva and cornea. Other factors such as corneal shape alteration and reduced tear production may decrease the rate of the drug elimination from the ocular surface and increase the time of the drug contact with the tissue. Both mechanisms will increase the dose of the drug penetration into the eye.
We suggest decreasing the use of topical steroids after LASIK surgery. Careful and close postoperative follow-up are required in patients with a family history of glaucoma or in glaucoma suspects.
